M. Lia Palomba, MD
Lymphoma Specialist & Cellular Therapist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Hodgkin and Non-Hodgkin Lymphomas
- Chronic Lymphocytic Leukemia (CLL)
- Waldenström’s Macroglobulinemia
About Me
- Attending Physician
I am a hematologist-oncologist who specializes in the study and treatment of lymphoma. My work focuses on the development of novel therapies for patients with B cell lymphoma, including indolent lymphomas (follicular, marginal zone, small lymphocytic), Waldenström’s macroglobulinemia, and chronic lymphocytic leukemia, as well as aggressive lymphoma, such as diffuse large-B cell lymphoma.
Read more
My research interest is in tumor immunology. I am involved in the development of novel therapies that exploit the immune system as a way to treat cancer. I am the head of hematological malignancies for the Cellular Therapeutics Center, which has played a fundamental role in the development and implementation of CAR T cell therapy. I am also interested in developing targeted therapies for lymphoma and in understanding the mechanisms by which these therapies work.
I am a member of the Waldenström’s macroglobulinemia Clinical Trial Group.
A lymphoma specialist is a doctor with special training in diagnosing and treating lymphoma.
A cellular therapy specialist is a doctor with special training in using cell therapies to treat health conditions such as cancer. Therapies can include chimeric antigen receptor (CAR) T cell therapy.
My Specialties
- Hodgkin and Non-Hodgkin Lymphomas
- Chronic Lymphocytic Leukemia (CLL)
- Waldenström’s Macroglobulinemia
- Translational Studies in Lymphoma
Education
- MD, University of Pavia
Residencies
- Internal Medicine - Mount Auburn Hospital
Fellowships
- Hematology - IRCCS Hospital San Mateo
- Hematology/Oncology - Memorial Sloan Kettering Cancer Center
- Medicine - Weill Cornell Medical College
Board Certifications
- Hematology (Italy)
- Internal Medicine
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Palomba sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Palomba
- A Phase 1 Study of CAR T Cell Therapy for People with HIV and B Cell Lymphoma
- A Phase 1 Study of PIT565 in People With B-Cell Non-Hodgkin Lymphoma
- A Phase 1 Study of SYNCAR-001 Plus STK-009 in People With Blood Cancers
- A Phase 2 Study of BGB-11417 in People With Waldenström's Macroglobulinemia
Read more
- A Phase I Study of Radiation Therapy Before CAR T Cell Therapy for People with B Cell Lymphoma
- A Phase II Study Assessing Venetoclax Added to Ibrutinib and Rituximab for Waldenström's Macroglobulinemia/Lymphoplasmacytic Lymphoma
- A Phase II Study of JCAR017 in People with Recurrent or Persistent Follicular Lymphoma or Marginal Zone Lymphoma
- Clinical Trials Co-Investigated by Dr. Palomba
- A Phase 1 Study of ABBV-525 in People With B-Cell Lymphoma
- A Phase I Study of BGB-16673 in People with B Cell Cancers
- A Phase I Study of Glofitamab Alone or in Combination with Obinutuzumab in People with Recurrent or Persistent Non-Hodgkin Lymphoma
- A Phase II Study of MB-CART2019.1 CAR T-Cell Therapy in People with Diffuse Large B-Cell Lymphoma
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Palomba’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
M. Lia Palomba discloses the following relationships and financial interests:
-
Bristol-Myers Squibb
Professional Services and Activities -
Cellectar Biosciences, Inc.
Professional Services and Activities
-
Mustang Bio
Professional Services and Activities -
Synthekine, Inc.
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].